Full View

Cardioprotective effects of LCZ696 (sacubitril/valsartan) after experimental acute myocardial infarction

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue… - Basic to Translational …, 2017 - jacc.org
Summary LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in
chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in …
被引用次数：96 相关文章

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

M Ishii, K Kaikita, K Sato, D Sueta… - JACC. Basic to …, 2017 - pubmed.ncbi.nlm.nih.gov
LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in chronic heart
failure. However, it is unclear whether LCZ696 can improve prognosis in patients with acute …

[引用][C] Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue… - JACC: Basic to …, 2017 - cir.nii.ac.jp
Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial
Infarction | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …
[HTML] sciencedirect.com

[HTML][HTML] Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue… - JACC: Basic to …, 2017 - Elsevier
Summary LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in
chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in …
[HTML] nih.gov

[HTML][HTML] Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

M Ishii, K Kaikita, K Sato, D Sueta… - JACC: Basic to …, 2017 - ncbi.nlm.nih.gov
SUMMARY LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in
chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in …
[PDF] researchgate.net

[PDF][PDF] Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue, Y Arima… - 2017 - researchgate.net
SUMMARY LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in
chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in …

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue… - JACC. Basic to …, 2017 - europepmc.org
LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in chronic heart
failure. However, it is unclear whether LCZ696 can improve prognosis in patients with acute …

Cardioprotective Effects of LCZ696 (sacubitril/valsartan) After Experimental Acute Myocardial Infarction

M Ishii - JACC: Basic to Translational Science, 2018 - kumadai.repo.nii.ac.jp
CME/MOC Objective for This Article: Upon completion of this activity, the learner should be
able to: 1) identify the potential cardioprotective mechanisms of LCZ696 in a mice model …

Cardioprotective Effects of LCZ696 (Sacubitril/Valsartan) After Experimental Acute Myocardial Infarction.

M Ishii, K Kaikita, K Sato, D Sueta, K Fujisue… - JACC. Basic to …, 2017 - europepmc.org
SUMMARY LCZ696 (sacubitril/valsartan) can lower the risk of cardiovascular events in
chronic heart failure. However, it is unclear whether LCZ696 can improve prognosis in …

[引用][C] Cardioprotective Effects of LCZ696 (sacubitril/valsartan) After Experimental Acute Myocardial Infarction

M Ishii - JACC: Basic to Translational Science, 2018 - kumadai.repo.nii.ac.jp